Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyang Lu

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Integrative Cancer Therapies|April 14, 2018
The Role and Mechanism of Borneol to Open the Blood-Brain BarrierTao Wu, Aiqin Zhang, Hongyang Lu, et al.
Biophysical Journal|September 30, 2004
Downhill kinetics of biomolecular interface binding: globally connected scenarioJin Wang, Weimin Huang, Hongyang Lu, et al.
Medical Oncology (Northwood, London, England)|March 9, 2020
Primary pulmonary lymphoepithelioma-like carcinomaYing Fan, Chenghui Li, Jing Qin, et al.
Translational Cancer Research|February 4, 2022
EGFR exon 20 insertion mutations in non-small cell lung cancerFenfang Wang, Chenghui Li, Qihuan Wu, et al.
Investigational New Drugs|January 9, 2025
The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacyMeihui Li, Xinyuan Wang, Jiali Gong, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
The efficacy of targeted therapy in ALK-positive non-small-cell lung cancer patients and analysis of MET/PD-L1 expression statusXinyuan Wang, Yi Chen, Dong Chen, et al.
Molecular and Clinical Oncology|July 24, 2014
A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancerHongyang Lu, Luo Fang, Xiaojia Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinibFenfang Wang, Jing Qin, Fajun Xie, et al.
Frontiers in Molecular Biosciences|November 11, 2021
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like CarcinomaYing Fan, Qianyun Shan, Jiali Gong, et al.
World Journal of Surgical Oncology|June 20, 2018
MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinomaLei Lei, Zhiming Jiang, Gu Zhang, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Integrative Cancer Therapies|April 14, 2018
The Role and Mechanism of Borneol to Open the Blood-Brain BarrierTao Wu, Aiqin Zhang, Hongyang Lu, et al.
Biophysical Journal|September 30, 2004
Downhill kinetics of biomolecular interface binding: globally connected scenarioJin Wang, Weimin Huang, Hongyang Lu, et al.
Medical Oncology (Northwood, London, England)|March 9, 2020
Primary pulmonary lymphoepithelioma-like carcinomaYing Fan, Chenghui Li, Jing Qin, et al.
Translational Cancer Research|February 4, 2022
EGFR exon 20 insertion mutations in non-small cell lung cancerFenfang Wang, Chenghui Li, Qihuan Wu, et al.
Investigational New Drugs|January 9, 2025
The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacyMeihui Li, Xinyuan Wang, Jiali Gong, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
The efficacy of targeted therapy in ALK-positive non-small-cell lung cancer patients and analysis of MET/PD-L1 expression statusXinyuan Wang, Yi Chen, Dong Chen, et al.
Molecular and Clinical Oncology|July 24, 2014
A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancerHongyang Lu, Luo Fang, Xiaojia Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinibFenfang Wang, Jing Qin, Fajun Xie, et al.
Frontiers in Molecular Biosciences|November 11, 2021
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like CarcinomaYing Fan, Qianyun Shan, Jiali Gong, et al.
World Journal of Surgical Oncology|June 20, 2018
MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinomaLei Lei, Zhiming Jiang, Gu Zhang, et al.
Pageof 13